Anebulo Pharmaceuticals adopts amended bylaws to comply with universal proxy rules

Anebulo Pharmaceuticals, Inc.

Board of Directors adopted Amended and Restated Bylaws on October 11, 2022.
Updated advance notice procedures for stockholder proposals to require additional information.
Added classified Board provision consistent with existing certificate of incorporation.
Implemented supermajority stockholder vote requirement for any future bylaw amendments.
Removed President's authority to call special meetings of stockholders or the Board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.